How Have the Numbers Shaped Up for Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD)

0
162

Earnings results for Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD)

Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingJun 2020 , the consensus EPS* forecast has remained the same over the past week at -0.41 and decreased over the past month from 999 to -0.41(100.04%). none raised and none lowered their forecast. For the fiscal year ending Dec 2020 , the consensus EPS* forecast has remained the same over the past week at -1.92 and decreased over the past month from 999 to -1.92(100.19%). none raised and none lowered their forecast.

Analyst Opinion on Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD)

4 Wall Street analysts have issued ratings and price targets for Repare Therapeutics in the last 12 months. Their average twelve-month price target is $25.50, predicting that the stock has a possible upside of 81.75%. The high price target for PYPD is $30.00 and the low price target for PYPD is $22.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Repare Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $25.50, Repare Therapeutics has a forecasted upside of 81.8% from its current price of $14.03. Repare Therapeutics has only been the subject of 4 research reports in the past 90 days.

Dividend Strength: Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD)

Repare Therapeutics does not currently pay a dividend. Repare Therapeutics does not have a long track record of dividend growth.

Insiders buying/selling: Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD)

In the past three months, Repare Therapeutics insiders have not sold or bought any company stock.

Earnings and Valuation of Repare Therapeutics Stock Forecast, Price & News (NASDAQ:PYPD

Earnings for Repare Therapeutics are expected to decrease in the coming year, from ($1.92) to ($2.27) per share.

More latest stories: here